Safety and immunogenicity of a bivalent HPV16/18 vaccine in Chinese females

Li-Wei Shia Institute of Vaccine Clinical Research, Guangxi Center for Disease Control and Prevention, Nanning, Guangxi, ChinaView further author information

Juan Lib Division of Respiratory Virus Vaccines, National Institute for Food and Drug Control, Beijing, ChinaView further author information

Bang-Wei Yuc Department of Regulatory and Medical Affairs, Shanghai Zerun Biotechnology Co. Ltd, Shanghai, ChinaView further author information

Li-Rong Huanga Institute of Vaccine Clinical Research, Guangxi Center for Disease Control and Prevention, Nanning, Guangxi, ChinaView further author information

Ke Lic Department of Regulatory and Medical Affairs, Shanghai Zerun Biotechnology Co. Ltd, Shanghai, ChinaView further author information

Min Jic Department of Regulatory and Medical Affairs, Shanghai Zerun Biotechnology Co. Ltd, Shanghai, ChinaView further author information

Ling-Yun Zhoud Quality Research Department, Shanghai Zerun Biotechnology Co., Ltd, Shanghai, ChinaView further author information

Lin Yuane Department of Regulatory and Medical Affairs, Walvax Biotechnology Co. Ltd, Kunming, Yunnan, ChinaView further author information

Shu-Yuan Yange Department of Regulatory and Medical Affairs, Walvax Biotechnology Co. Ltd, Kunming, Yunnan, ChinaView further author information

Jing-Jing Chene Department of Regulatory and Medical Affairs, Walvax Biotechnology Co. Ltd, Kunming, Yunnan, ChinaView further author information

Ling Wangg Department of Health Statistics, Air Force Military Medical University, Xi’an, Shanxi, ChinaView further author information

Zhi-Wei Jiangf Department of Health Statistics, Beijing Key Tech Statistical Technology Co. Ltd, Beijing, ChinaView further author information

Rong-Cheng Lia Institute of Vaccine Clinical Research, Guangxi Center for Disease Control and Prevention, Nanning, Guangxi, ChinaView further author information

Yan-Ping Lia Institute of Vaccine Clinical Research, Guangxi Center for Disease Control and Prevention, Nanning, Guangxi, ChinaView further author information

Jie-Lai Xiag Department of Health Statistics, Air Force Military Medical University, Xi’an, Shanxi, ChinaCorrespondence[email protected]
View further author information

Zhao-Jun Moa Institute of Vaccine Clinical Research, Guangxi Center for Disease Control and Prevention, Nanning, Guangxi, ChinaCorrespondence[email protected]
View further author information

Chang-Gui Lib Division of Respiratory Virus Vaccines, National Institute for Food and Drug Control, Beijing, ChinaCorrespondence[email protected]
View further author information

Your download is now in progress and you may close this window